| 1 |
32449282 | Anticancer targets and mechanisms of calycosin to treat nasopharyngeal carcinoma. | 2020 Jul |
2 |
| 2 |
29096683 | Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling. | 2017 Nov 2 |
1 |
| 3 |
26956998 | Suppression of A549 cell proliferation and metastasis by calycosin via inhibition of the PKC-α/ERK1/2 pathway: An in vitro investigation. | 2016 Apr |
1 |
| 4 |
26498639 | Suppression of A549 cell proliferation and metastasis by calycosin via inhibition of the PKC‑α/ERK1/2 pathway: An in vitro investigation. | 2015 Dec |
1 |
| 5 |
24618835 | Calycosin suppresses breast cancer cell growth via ERβ-dependent regulation of IGF-1R, p38 MAPK and PI3K/Akt pathways. | 2014 |
3 |
| 6 |
21612861 | Calycosin promotes proliferation of estrogen receptor-positive cells via estrogen receptors and ERK1/2 activation in vitro and in vivo. | 2011 Sep 28 |
3 |
| 7 |
21669275 | Calycosin protects HUVECs from advanced glycation end products-induced macrophage infiltration. | 2011 Sep 1 |
3 |